Francesco Meo - Fresenius CEO

FSNUY Stock  USD 6.76  0.12  1.81%   

CEO

Dr. Francesco De Meo is Member of the Management Board and Chief Executive Officer of Business Segment Fresenius Helios at Fresenius SE Co KGaA since January 1, 2008. In 2000, Dr. De Meo became head of the legal and human resources departments of HELIOS Kliniken GmbH. On January 1, 2001, he was appointed to the HELIOS Kliniken Management Board with responsibilities for human resources, legal affairs, research and science. At the same time, he was also appointed Labor Relations Director. Before joining HELIOS, he was Director of Rauser AG, a management consultancy in Reutlingen, as well as a practicing Attorney. Currently, he serves as Chairman of the Supervisory Boards of Helios Beteiligungs AG and Helios Kliniken Schwerin GmbH. He studied Law and earned a Doctorate degree at Eberhard Karls Universitaet Tuebingen. since 2008.
Age 60
Tenure 16 years
Professional MarksPh.D
Phone49 6172 608 2487
Webhttps://www.fresenius.com

Fresenius Management Efficiency

The company has return on total asset (ROA) of 0.0292 % which means that it generated a profit of $0.0292 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0793 %, meaning that it generated $0.0793 on every $100 dollars invested by stockholders. Fresenius' management efficiency ratios could be used to measure how well Fresenius manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 27.16 B in total debt with debt to equity ratio (D/E) of 0.89, which is about average as compared to similar companies. Fresenius SE has a current ratio of 1.29, suggesting that it is not liquid enough and may have problems paying out its financial obligations in time and when they become due. Debt can assist Fresenius until it has trouble settling it off, either with new capital or with free cash flow. So, Fresenius' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Fresenius SE sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Fresenius to invest in growth at high rates of return. When we think about Fresenius' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

CEO Age

Paolo MartinSCOR PK
49
Emmy LeekaBarloworld Ltd ADR
N/A
Clive ThomsonBarloworld Ltd ADR
48
Victor PeignetSCOR PK
55
Benjamin GentschSCOR PK
56
John RisherLYFT Inc
59
JeanPaul ConoscenteSCOR PK
53
Gilles MeyerSCOR PK
56
Francois VarenneSCOR PK
50
Simon PearsonSCOR PK
49
Laurent RousseauSCOR PK
44
Brona MageeSCOR PK
47
Viktor SalzmannBarloworld Ltd ADR
67
Peter BultermanBarloworld Ltd ADR
60
George HagerGen Digital
63
Peter BlackbeardBarloworld Ltd ADR
57
KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Hhe, Germany. Fresenius operates under Medical Care Facilities classification in the United States and is traded on OTC Exchange. It employs 318647 people. Fresenius SE Co [FSNUY] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC).

Management Performance

Fresenius SE Leadership Team

Elected by the shareholders, the Fresenius' board of directors comprises two types of representatives: Fresenius inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Fresenius. The board's role is to monitor Fresenius' management team and ensure that shareholders' interests are well served. Fresenius' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Fresenius' outside directors are responsible for providing unbiased perspectives on the board's policies.
Rachel Empey, CFO, Member of the Management Board
KlausPeter Mueller, Member of the Supervisory Board
Roland Berger, Member of the Supervisory Board
Mats Henriksson, Member of the Management Board, CEO Fresenius Kabi
Michael Albrecht, Member of the Supervisory Board
Michael Sen, Pres CEO
Sara Hennicken, Chief Officer
Ernst Wastler, Member of the Management Board - Fresenius Management SE and CEO of Fresenius Vamed
Dieter Schenk, Deputy Chairman of the Supervisory Board and Lawyer and Tax Consultant
Frauke Lehmann, Member of the Supervisory Board
Matthias Link, Sr Communications
Markus Georgi, Senior Vice President Investor Relations
Dario Ilossi, Member of the Supervisory Board, Employee Representative
Stephan Sturm, CFO of Fresenius Management SE and Member of the Management Board - Fresenius Management SE
Gregor Zuend, Member of the Supervisory Board
Konrad Koelbl, Member of the Supervisory Board
Niko Stumpfoegger, Deputy Chairman of the Supervisory Board, Employee Representative
Francesco Meo, Member of the Management Board - Fresenius Management SE and CEO of Fresenius Helios
Bernd Behlert, Independent Member of the Supervisory Board
Ulf Schneider, Chairman of the Management Board - Fresenius Management SE, CEO of Fresenius Management SE and President of Fresenius Management SE
Oscar Paco, Member of the Supervisory Board
Helen Giza, Member SE
Dieter Reuss, Member of the Supervisory Board
Sebastian Biedenkopf, HR, Officer
Gerhard Roggemann, Member of the Supervisory Board
Stefan Schubert, Member of the Supervisory Board, Employee Representative
Hauke Stars, Member of the Supervisory Board
Stefanie Lang, Member of the Supervisory Board
Iris LoewFriedrich, Member of the Supervisory Board
Juergen Goetz, Chief Legal and Compliance Officer, Labor Relations Director, Member of the Management Board
Michael Diekmann, Member of the Supervisory Board
Rice Powell, Member of the Management Board
Carla Kriwet, Members SE
Gerd Krick, Chairman of the Supervisory Board
Rainer Stein, Member of the Supervisory Board, Employee Representative

Fresenius Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Fresenius a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Fresenius in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Fresenius' short interest history, or implied volatility extrapolated from Fresenius options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fresenius SE Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in employment.
You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Complementary Tools for Fresenius Pink Sheet analysis

When running Fresenius' price analysis, check to measure Fresenius' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius is operating at the current time. Most of Fresenius' value examination focuses on studying past and present price action to predict the probability of Fresenius' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius' price. Additionally, you may evaluate how the addition of Fresenius to your portfolios can decrease your overall portfolio volatility.
Bonds Directory
Find actively traded corporate debentures issued by US companies
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
CEOs Directory
Screen CEOs from public companies around the world
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Please note, there is a significant difference between Fresenius' value and its price as these two are different measures arrived at by different means. Investors typically determine if Fresenius is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fresenius' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.